Policy News
-
Study Analyzes Potential Impact of Drug Pricing Proposals
Congress is once again turning its attention to drug pricing, including the proposed use of foreign reference pricing…
-
President Biden Unveils Sweeping $2 Trillion Infrastructure Plan
On Wednesday, President Biden unveiled the first installment of his two-part Build Back Better plan – a sweeping…
-
BioUtah Urges MCIT Implementation
BioUtah has submitted a comment letter to CMS in response to concerns raised by the Biden administration around…
-
Impact of International Reference Pricing on Drug Innovation
Policymakers in Washington are considering plans to replace the current market-based system for pricing prescription medicines with a…
-
President Biden Signs $1.9 Trillion COVID-19 Relief Bill
Yesterday, President Biden signed into law the American Rescue Plan (H.R. 1319), a $1.9 trillion COVID-19 relief package…
-
BioUtah Recognizes Rare Disease Day
Today, BioUtah recognizes Rare Disease Day – its patients, families, healthcare providers, advocates, policymakers and drug manufacturers –…
-
BioUtah Hosts LIfe Sciences Roundtable with Congressional Healthcare Leaders
BioUtah recently held a life sciences industry roundtable with Republican lawmakers in the U.S. House of Representatives who…
-
Control Medical Technology Announces New Device Removes Large Blood Clots in 1st Deep Vein Thrombosis (DVT) Patient Use
Control Medical Technology today announced the FDA cleared Control 11F Mechanical Thrombectomy system was used to remove large…
-
President Biden Unveils COVID-19 Vaccine Plan
In an effort to speed up vaccinations after a slower than expected rollout, HHS last week began encouraging…
-
President Biden Unveils COVID-19 Relief Plan
President Biden has unveiled the first part in his two-part plan for rescue and economic recovery—the American Rescue…
-
Day One – Biden Administration Issues Regulatory Freeze
Issuing a regulatory freeze is standard practice for an incoming administration, so as expected, shortly after President Biden…
-
President Biden Signs Flurry of Executive Orders on COVID-19, $15 Minimum Wage for Federal Workers, Buy American Next
Following his inauguration on January 20, President Biden signed 17 executive orders — including several aimed at COVID-19…
-
Present at BIO-Europe Spring® Digital
Apply to Present at BIO-Europe Spring® Digital NEW deadline to apply is January 20. View Presentation Options…
-
LS & Pharmaceuticals Industry Report
This report offers a high-level overview focused mainly on the pharmaceutical industry, related capital events – incl. investments…
-
BioUtah Joins Patient Groups Opposing MFN
BioUtah joined numerous patient advocates and healthcare providers in sending a letter to U.S. House and Senate leaders…
-
Reddyport’s New Non-Invasive Ventilation Products to Allow Patient Communication/Oral Care is Funded Through Launch
ReddyPort has announced it has raised Seed Funding to support launch of its non-invasive ventilation (NIV) products in…
-
Congress Passes $900 Billion COVID Stimulus Package While Trump Calls for $2,000 in Direct Payments
Both the House of Representatives and the Senate passed on Monday a more than $900 billion COVID-19 stimulus…
-
Congress Nears Deal on COVID-19 Stimulus Package
Leaders of both parties inched closer on Thursday to agreement on a COVID-19 stimulus package. The package would…
-
Drug Industry Trade Groups File Lawsuits on Most-Favored-Nation Pricing Rule
The Trump administration recently announced an interim final rule to implement the Most Favored Nation drug pricing model, which would…
-
Bio€quity Europe
Register here.
-
BioUtah Letter on Prioritizing Life Sciences Workers for Vaccine Distribution
December 3, 2020 Mr. Rich Lakin, MSPH, MPA Immunizations Director Utah Department of Health Bureau of Epidemiology PO…
-
BIO to Issue Legal Challenge to Most Favored Nation Rule
A letter written by BIO’s president and CEO Michelle McMurry-Heath dated December 4, 2020. Dear BIO Members, Today…
-
Who’s First In Line for the COVID Vaccine? CDC’s Immunization Advisory Committee Makes Recommendations
With the first shipments of the Pfizer/BioNTech vaccine scheduled to arrive in a matter of weeks and Moderna…
-
BioUtah Urges State to Prioritize Life Sciences Workers in COVID-19 Vaccine Plan
With the CDC’s prioritization recommendations as guidance, states will make the final decisions about vaccine allocation in their…
-
Representative McAdams Honored with the 2020 Champion of Health Care Innovation Award
In a virtual December 3 ceremony, the American Life Sciences Innovation Council (ALSIC), BioUtah and several state and…
-
Gov.-Elect Cox and Lt. Gov.-Elect Henderson Announce Key Appointments, More to Come
SALT LAKE CITY (Dec. 2, 2020) – Gov.-elect Spencer Cox and Lt. Gov.-elect Deidre Henderson have announced another…
-
A Farewell Message from GOED’s Val Hale
I frequently remind my team and legislators that economic development is a journey, not a destination. And what…
-
BraveHeart Wireless Partners with iKure and IBM
The three companies have partnered together to bring wearable BraveHeart patches to at-risk patient’s in India’s remote “last…
-
New Embolic Device Used in Interventional Oncology for Highly Targeted Tumor Treatment
Novel Interventional Oncology Embolization Device Successfully Used in Trans-Radial Access Procedures for Tumor Devascularization November 24, 2020 –…
-
Governor Herbert Updates State of Emergency, New Public Health Order Issued, Revisions to Employee Quarantine
Governor Herbert’s previous State of Emergency ended at midnight Monday, November 23 and a new public health order…
-
Most Favored Nation Rule Poses Patient Access Issues, Faces Legal Challenges
As reported in last week’s BioUtah News and Events, HHS on Nov. 20 released an interim final rule…
-
Milken Institute Ranks Utah Sixth in Nation for Innovation Capacity
The Milken Institute 2020 State Technology and Science Index ranks Utah #6 in the nation for its knowledge…
-
FDA Posts Serology Templates for Test Developers
The FDA on Nov. 24 posted two templates with recommendations on what to include in EUA requests for…
-
University of Utah to Speed Process of Bringing New Therapeutics to Patients
University of Utah Partners for Innovation, Ventures, Outreach & Technology (PIVOT) Center: Nov 18, 2020 10:00 AM The…
-
U named Innovation and Economic Prosperity University
Article Courtesy of @theU The Association of Public and Land-grant Universities (APLU) awarded the University of Utah the Innovation…
-
Sanofi Commits $1M to Support Parkinson’s Disease Genetic Research
Sanofi and the Parkinson’s Foundation announced on Wednesday a new research collaboration to advance the availability of genetic…
-
SBA Extends PPP Loan Deferral, New Streamlined Forgiveness for Loans of $50,000 or Less
On October 7, the SBA released updated FAQs (question #52) to clarify that lenders must recognize the extended…
-
Pediatric Rare Disease Voucher Program Extended
Congress recently provided a short-term extension until December 11 of the Rare Pediatric Disease Priority Review Voucher program.…
-
Trump Administration Issues Final Drug Importation Rule
On September 24, the Trump Administration released a final rule to allow the importation of prescription drugs from…
-
President Trump Signs Executive Order on Healthcare, Pre-existing Conditions
During a campaign event yesterday in Charlotte, North Carolina, President Trump signed an executive order on a range…
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8M Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial…
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
